Please assess the completion status of the following clinical trial:

Trial Title: A(f)MAZE-CABG Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Legal age in host country~* Scheduled for CABG surgery~* Patient suffering from persistent or long-standing persistent AF~* Patients having the ability to fully comply with the study requirements~* Life expectancy \> 2 years~* Patients who have given written informed consent to participate in the study~Exclusion Criteria:~* Clinically significant local or systemic infection or active endocarditis~* Sutures, pacing/defibrillator leads on the left side of the heart, valve prostheses or rings, or other implanted material in or adjacent to target treatment area.~* Stent in the coronary artery preventing an adequate mitral line~* Any other concomitant operation on the heart~* Previous heart surgery~* Patients who are or may potentially be pregnant~* Previous catheter ablation for atrial arrhythmia~* LA size more than 60 mm in apical view on Trans-Thoracic Echocardiogram (TTE)~* LA thrombus on intra-operative Trans-Oesophageal Echocardiogram (TOE)~* Known contraindication to Amiodarone~* Inability to undergo TOE~* Patients who are unable to give full informed consent for the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Concomitant HIFU ablation (Type: ACTIVE_COMPARATOR): HIFU AF Ablation
- Best medical treatment (Type: NO_INTERVENTION): Best medical treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).